Quotient Sciences

Early Clinical Development Partner with us to design and deliver your early clinical programs.

With experience spanning 35 years and more than 1,300 Phase I studies delivered, learn how #QuotientSciences can help accelerate to first-in-human and proof of concept milestones with confidence: bit.ly/3KX2X4r

Dr. Andrew Lewis featured in Pharma Source Article, "How to Build Resilient Pharma-CDMO Partnerships in 2025"

Dr. Andy Lewis, Chief Scientific Officer, recently contributed to PharmaSource's article, "How to Build Resilient Pharma-CDMO Partnerships in 2025". Hear Dr. Lewis' perspective on building lasting partnerships that can withstand the industry challenges of today: bit.ly/4pZM5dv

Global Compact Network UK We're Flying the Flag

We’re raising the UN Sustainable Development Goals (SDGs) flag today in recognition of our focus on turning ambition into action across our sites and teams #togetherfortheSDGs with the UN Global Compact Network UK.

Learn more about our ongoing commitment to #ESG initiatives: bit.ly/42OPC3F

The Benefits of an Integrated Compounding & GMP Manufacturing Strategy: A Q&A with Our Experts

Dr. Dolly Jacob, Director of Integrated Development Services, discusses capabilities of our Miami, FL on-site compounding pharmacy to accelerate first-in-human to proof-of-concept #clinicaltrials: bit.ly/4fr4wD2

Quotient Sciences News Quotient Sciences Featured in Contract Pharma's feature on HPAPI Outsourcing Robert Cornog Brad Rowe

Robert Cornog, Senior Director of Product Development & Brad Rowe, Senior Director of Integrated Development contributed to Contract Pharma's feature on #HPAPI outsourcing, speaking on the demand, #regulatory shifts, and analytical challenges shaping the contract manufacturing market. bit.ly/4njmfPF

Last week, we celebrated 35 years of #QuotientSciences. Our CEO, Thierry Van Nieuwenhove, reflects on our mission and success in combining science, agility, and culture to make a real difference for our customers, partners, and the lives of people around the world. Learn more: bit.ly/3SeKCQV

Quotient Sciences News Quotient Sciences and CPI to Accelerate RNA Drug Development with Joint Venture Read Announcement

NEWS: Quotient Sciences and CPI's joint venture marks a major step forward in RNA drug development.

Using our Translational Pharmaceutics® platform and CPI’s RNA manufacturing expertise, we aim to streamline the development of promising treatments for patients. Read announcement: bit.ly/4lMKRin

Quotient Sciences Info Sheet Formulation Development

Our #formulationdevelopment services support customers from preclinical to late-stage clinical evaluation. Learn more about how we can help address formulation issues quickly and optimize your molecule's performance: bit.ly/4lYTVBB

Quotient Sciences Blog Poster Spotlight: Taste Assessment Study of Tenapanor Pediatric Solution Formulations Nazim Kanji, Executive Director of Pediatric Services

Latest #blog: Nazim Kanji, Executive Director of Pediatric Services, summarizes findings from a poster focusing on a taste assessment study of tenapanor pediatric solution formulations from EuPFI 2023. Read here: bit.ly/411T76S

Modified-Release Formulation Strategies With over 30 years of formulation expertise and over 100 MR programs developed, the team at Quotient Sciences possess the experience, capabilities, and technologies needed to create a successful MR fo...

Careful selection of appropriate delivery technologies is key to the design of successful modified-release formulations. Download our info sheet to learn how we can help reduce development risks and maximizing the chance of success for your treatment: bit.ly/4f6kwKI

Quotient Sciences The Benefits of an Integrated Compounding & GMP Manufacturing Strategy: A Q&A with Our Experts Dr. Dolly Jacob

In our latest blog, Dr. Dolly Jacob, Director of Integrated Development Services, speaks about the capabilities of our Miami, FL on-site compounding pharmacy and ideal uses for pharmacy compounding to accelerate FIH to POC trials. Learn more: bit.ly/4fr4wD2

Quotient Sciences News BIO International 2025 Wrap-up: Quotient Sciences Experts Share Industry Insight Robert Cornog Dr. Kevin Schaab

#ICYMI: Robert Cornog, Senior Director of Product Development, and Dr. Kevin Schaab, Senior Drug Development Consultant, share their insight about their visit to BIO International Convention 2025: bit.ly/44knuWS

Quotient Sciences Our latest whitepaper Clinical and formulation strategies for targeted peptide delivery Download now

Dr. Andy Lewis, Chief Scientific Officer, examines how CMC and clinical strategies for #peptide drugs can be improved, answering questions on the challenges and potential solutions associated with development of injectable and oral peptide drugs in our latest whitepaper: bit.ly/4kPtcGP

Quotient Sciences News John McDermott Contributes to Pharmaceutical Outsourcing Oral Solid Dosage Roundtable

In this article from Pharmaceutical Outsourcing, John McDermott, VP of Scientific Consulting, talks about the evolving landscape of oral solid dosage manufacturing and highlights the importance of small, agile #CDMOs to meet the diverse demands of modern #drugdevelopment. bit.ly/4lmAjHd

Quotient Sciences Announces Formation of Scientific Advisory Board Advisory board will contribute to driving innovation and technology aligned with company strategic priorities. Inaugural board participants include established pharma & biotech executives, academics.

Latest news: #QuotientSciences has formed a scientific advisory board of established leaders from industry and academia. The board will contribute to driving innovation and technology aligned with company strategic priorities. bit.ly/3TOukPs

Quotient Sciences Our Latest Whitepaper A Road Map To Expedited Review Pathways Download Now

Latest #whitepaper: Learn more about how we help customers navigate the #drugdevelopment pathway, meeting the #regulatory requirements of products granted expedited development and review, as well as generating data needed to support drug approval. Download today: bit.ly/46g7KqD

Navigating Expediated Drug Development Pathways Globally: Q&A with Quotient Sciences Experts

In our latest blog, Brad Rowe, Senior Director of Integrated Development, and Robert Cornog, Senior Director of Product Development, share insight on how our team can help clients successfully leverage accelerated approval pathways.

Read more: bit.ly/4lrooIc

Quotient Sciences re-introduces Arcinova

Latest announcement: Quotient Sciences announces the reintroduction of Arcinova - A Quotient Sciences Company.

Through a focus on quality, science, and innovation, Arcinova provides innovative research, development, and manufacturing services to advance drug development. Reade more: bit.ly/3HWORif

Quotient Sciences BioPharm International interviews Dr. Helen Baker

#ICYMI: In this video interview with BioPharm International, Dr. Helen Baker, Director of Formulation Design, discusses the benefits of having #clinical, late-stage, and #regulatory processes under one provider. Learn more: bit.ly/3XKlchg

Our Philadelphia teams are committed to delivering high-quality services for #drugproduct formulation & manufacturing. Learn about the important role these sites have in facilitating #TranslationalPharmaceutics® programs in collaboration with our Miami clinical pharmacology facility: bit.ly/422ysQR

Quotient Sciences News Poor API Quality Threatens a Healthy Supply Dr. Helen Baker Dr. Richard Castledine

#ICYMI: Dr. Helen Baker, Director of Formulation Design, and Dr. Richard Castledine, Head of Drug Substance Operations, contributed to Pharmaceutical Technology's issue, 'Poor API Quality Threatens a Healthy Supply'. Learn more about the importance of high quality API: bit.ly/3FczGjU

Translational Pharmaceutics® Integrated Drug Development Info Sheet Quotient Sciences Translational Pharmaceutics® platform for drug development helps you achieve your goals by enabling a significantly faster transition through drug development by integrating on-deman...

#TranslationalPharmaceutics® has been a core part of #QuotientSciences’ approach for nearly two decades. Download our recently updated info sheet to learn more about how it works to accelerate drug programs: bit.ly/4iH9JqI

Quotient Sciences News Poor API Quality Threatens a Healthy Supply Dr. Helen Baker Dr. Richard Castledine

Dr. Helen Baker, Director of Formulation Design, and Dr. Richard Castledine, Head of Drug Substance Operations, contributed to Pharmaceutical Technology's latest issue, 'Poor API Quality Threatens a Healthy Supply'. Learn more about the importance of high quality API here: bit.ly/3FczGjU

Quotient Sciences Event CPHI Americas May 20-22 - Philadelphia, PA Connect with us at booth #1220

Will you be in Philadelphia for #CPHIAmericas next week? Meet with our team at booth #1220 to learn more about our expanded service offerings and how #QuotientSciences can help you overcome your program challenges. Request a meeting today: bit.ly/3G1GIbr

We recently celebrated #NursesWeek and #ClinicalOperations Appreciation Day at our Miami and Nottingham sites! We are proud to recognize the hard work and dedication of our teams each day! #lifeatquotient

Quotient Sciences Article Pharmacokinetics, Pharmacodynamics, and Bioavailability of ACM-001.1 (S. Pindolol Benzoate) in Healthy Volunteers

#ICYMI: Learn about our work in a two-part study assessing the comparative #bioavailability, #pharmacokinetics, and #pharmacodynamics of ACM-001.1 (S-Pindolol Benzoate) in healthy volunteers. bit.ly/4kwTm1V

Quotient Sciences Blog Using a Formulation Design Space with Translational Pharmaceutics for Success in Oral Peptide Development Dr. Andrew Lewis Chief Scientific Officer

In our latest blog, Dr. Andy Lewis, Chief Scientific Officer, discusses how recent advancements in #drugdiscovery, #peptide engineering, and #drugdelivery have converged to address many of the challenges associated with oral peptide delivery. Read more: bit.ly/3EXXcBa

Quotient Sciences Blog How an Integrated Approach to Project Management Helps Advance Drug Development: A Look into Quotient Sciences' Project Management Function Sue Sweet-Smith - Senior Director, Project Management

In our latest #blog, hear from Sue Sweet-Smith, Senior Director of Project Management, on how our unique approach to #projectmanagement helps to minimize risks and simplify the #drugdevelopment process. Read more: bit.ly/4iP401J

Quotient Sciences Blog Spotlight on Nottingham: Q&A with Denise Sutton - Part 2 Denise Sutton, Chief Operating Officer and Site Head - Nottingham, UK

In this feature of our #blog spotlight, Denise Sutton, Chief Operating Officer and Site Head - Nottingham, UK, speaks on the strengths, expertise, and dedication of our #projectmanagement team, including how we work with our customers to determine the right program for their needs. bit.ly/3RCNVkz

Quotient Sciences Our Latest Whitepaper How to Optimize CMC and Clinical Strategies for Injectable & Oral Peptide Drugs Download Now

Peptides are attractive drug candidates however they often face many challenges in development. In this #whitepaper, Dr. Andy Lewis breaks down how recent advances in #drugdiscovery and #peptide engineering have led to significant progress in overcoming such challenges. Download here: bit.ly/3Rh0FNH